PRODUCTS

ZqhZoPJFLplSO

ZqhZoPJFLplSO (2276)

17403

I've lost my bank card nexium b12 mangel Drugmaker Retrophin Inc said it offered to buy therest of Transcept Pharmaceuticals shares it does not already ownfor $4 per share, valuing Transcept at about $75 million.Retrophin's offer represents an 11 percent premium toTranscept's closing share price of $3.59 on the Nasdaq onWednesday.

I've lost my bank card nexium b12 mangel Drugmaker Retrophin Inc said it offered to buy therest of Transcept Pharmaceuticals shares it does not already ownfor $4 per share, valuing Transcept at about $75 million.Retrophin's offer represents an 11 percent premium toTranscept's closing share price of $3.59 on the Nasdaq onWednesday.

£116.40 Including VAT

Website maintained by CIUK